WHO consolidated guidelines on tuberculosis: module 6: tuberculosis and comorbidities
29 April 2024
| Guideline
Overview
Addressing
comorbidities and risk factors for tuberculosis (TB) is a crucial
component of the World Health Organization (WHO)’s End TB Strategy.
These consolidated guidelines on tuberculosis. Module 6: tuberculosis
and comorbidities summarize the latest WHO recommendations on TB and key
comorbidities. It is a living document and will include a separate
section for each of the key TB comorbidities or health-related risk
factors. This first edition focuses on interventions to address
HIV-associated TB and is an update of the WHO policy on collaborative
TB/HIV activities: guidelines for national programmes and other
stakeholders. People with HIV are 12–16 times more likely to develop TB
disease, have poorer TB treatment outcomes and have three-fold higher
mortality during TB treatment compared to people without HIV. Despite
advances in the screening, diagnosis, treatment and prevention of TB
disease, TB remains the leading cause of death among people with HIV
worldwide.
These
consolidated guidelines are intended for use by people working in
ministries of health, particularly TB programmes and the relevant
departments or programmes responsible for comorbidities and
health-related risk factors for TB, as well as programmes addressing
mental health and lung health, implementing partners including technical
and funding agencies, civil society and representatives of affected
communities, clinicians and public health practitioners.
WHO Team
Global Tuberculosis Programme (GTB),
Guidelines Review Committee
Editors
World Health Organization
Number of pages
90
Reference numbers
ISBN: 978-92-4-008700-2